PL04.03 Safety and Efficacy of BAY 2927088 In Patients with HER2-Mutant NSCLC: Expansion Cohort from the Phase I/II SOHO-01 Study

Xiuning Le, Nicolas Girard, P.A. Jänne, S. Novello, Hye Ryun Kim, Herbert H. Loong, Boon Cher Goh, Ki Hyeong Lee, Kazumi Nishino, Shun Lu, Xuebing Dong, J. Zhao, T.A. Leal, Daniel Shao-Weng Tan, Kōichi Goto, Tine Descamps, Barbara J. Brennan, Rachel Li, Paolo Grassi, T.M. Kim